Type
Global appeal 2008 to end stigma and discrimination against people affected by leprosy : Endorsed by human rights oriented ngos [Internet]. The Global Appeal. London; 2008. Report No.: GA2008. Available from: http://www.nippon-foundation.or.jp/en/what/projects/leprosy/appeal/8f0j6k000009yfbq.pdf
Type
Melchior H, Velema J. A comparison of the Screening Activity Limitation and Safety Awareness (SALSA) scale to objective hand function assessments. Disability and rehabilitation. 2011;33(21-22):2044-52.
Type
Levis W, Martiniuk F. Psoriasis and leprosy are teaching us T-cell plasticity. Journal of drugs in dermatology : JDD. 2013;12(10):1082.
Type
Richardus R, Alam K, Pahan D, Feenstra S, Geluk A, Richardus JH. The combined effect of chemoprophylaxis with single dose rifampicin and immunoprophylaxis with BCG to prevent leprosy in contacts of newly diagnosed leprosy cases: a cluster randomized controlled trial (MALTALEP study). BMC infectious diseases [Internet]. 2013;13:456. Available from: http://www.biomedcentral.com/content/pdf/1471-2334-13-456.pdf
Type
Figueiredo IA, Aquino DMC, Jesus Mendes Caldas A, Goulart IMB, Pereira SRF, Serra HO, et al. Neural complications and physical disabilities in leprosy in a capital of northeastern Brazil with high endemicity. Revista brasileira de epidemiologia [Internet]. 2014;17(4):899-910. Available from: http://www.scielo.br/pdf/rbepid/v17n4/1415-790X-rbepid-17-04-00899.pdf
Type
Voorend C, Post E. A systematic review on the epidemiological data of erythema nodosum leprosum, a type 2 leprosy reaction. PLOS Neglected Tropical Diseases [Internet]. 2013;7(10):e2440. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789767/pdf/pntd.0002440.pdf
Type
Vora R, Pilani A. Epidermotropism of lepra bacilli in a patient with histoid Hansen's disease. Indian dermatology online journal [Internet]. 2014;5(4):504-7. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228654/
Type
Kantaria S. De novo histoid leprosy. Indian dermatology online journal [Internet]. 2014;5(4):556-8. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228681/
Type
Ribeiro S, Pereira H, Silva N, Sato E, Passos L, Dos-Santos M. Long-term persistence of anti-β2 glycoprotein I in treated leprosy patients. Lupus. 2014;23(12):1249-51.
Type
Global appeal 2012 to end stigma and discrimination against people affected by leprosy : Endorsed by members of The World Medical Association [Internet]. The Global Appeal. Sao Paulo; 2012. Report No.: GA2012. Available from: http://www.nippon-foundation.or.jp/en/what/projects/leprosy/appeal/8f0j6k00000bkhyj.pdf